Envisioneering Medical Technologies is an innovative medical technology company that develops, manufactures and markets proprietary diagnostic and treatment guidance solutions for the healthcare marketplace. Based in St. Louis, Envisioneering was founded to continue development and commercialization of a unique and proprietary scanning technology that uses ultrasound imaging to guide diagnostic biopsy sampling and to guide treatment delivery. Uniquely keeping the probe stationary improves the confidence of biopsy and treatment delivery enables new generations of diagnostic and treatment devices to be incorporated into medical care.. The Company's initial product offering, the TargetScan® System for prostate imaging and biopsy, combines proprietary robotic ultrasound technology with the capability to perform precise, targeted prostate biopsies and treatments in order to add confidence to patient diagnosis. Clinical applications using Envisioneering's proprietary and cost effective ultrasound based technology, has become the standard of care in select clinics nationwide.
Envisioneering's mission is to develop and introduce a robotic scanning technology to contribute to improvements in diagnostic and treatment outcomes for prostate disease. The technology is intended to support new generations of targeted treatments that will drive how prostate disease is managed in the future. Envisioneering's proprietary technology is cost effective, imaging based and designed with real-world clinical applications in mind to contribute to the best standard of patient care.